Cargando…
PB2276: EARLY ADMINISTRATION OF REMDESIVIR PLUS CONVALESCENT PLASMA THERAPY IS EFFECTIVE TO TREAT COVID-19 PNEUMONIA IN B-CELL DEPLETED PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431478/ http://dx.doi.org/10.1097/01.HS9.0000851932.19116.3c |
| _version_ | 1784780066623848448 |
|---|---|
| author | Pinczes, L. I. Magyari, F. Páyer, E. Farkas, K. Ujfalusi, S. Diószegi, Á. Deme, A. Sik, M. Nagy, G. Hevessy, Z. Nagy, B. Illés, Á. |
| author_facet | Pinczes, L. I. Magyari, F. Páyer, E. Farkas, K. Ujfalusi, S. Diószegi, Á. Deme, A. Sik, M. Nagy, G. Hevessy, Z. Nagy, B. Illés, Á. |
| author_sort | Pinczes, L. I. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431478 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94314782022-08-31 PB2276: EARLY ADMINISTRATION OF REMDESIVIR PLUS CONVALESCENT PLASMA THERAPY IS EFFECTIVE TO TREAT COVID-19 PNEUMONIA IN B-CELL DEPLETED PATIENTS WITH HEMATOLOGICAL MALIGNANCIES Pinczes, L. I. Magyari, F. Páyer, E. Farkas, K. Ujfalusi, S. Diószegi, Á. Deme, A. Sik, M. Nagy, G. Hevessy, Z. Nagy, B. Illés, Á. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431478/ http://dx.doi.org/10.1097/01.HS9.0000851932.19116.3c Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Pinczes, L. I. Magyari, F. Páyer, E. Farkas, K. Ujfalusi, S. Diószegi, Á. Deme, A. Sik, M. Nagy, G. Hevessy, Z. Nagy, B. Illés, Á. PB2276: EARLY ADMINISTRATION OF REMDESIVIR PLUS CONVALESCENT PLASMA THERAPY IS EFFECTIVE TO TREAT COVID-19 PNEUMONIA IN B-CELL DEPLETED PATIENTS WITH HEMATOLOGICAL MALIGNANCIES |
| title | PB2276: EARLY ADMINISTRATION OF REMDESIVIR PLUS CONVALESCENT PLASMA THERAPY IS EFFECTIVE TO TREAT COVID-19 PNEUMONIA IN B-CELL DEPLETED PATIENTS WITH HEMATOLOGICAL MALIGNANCIES |
| title_full | PB2276: EARLY ADMINISTRATION OF REMDESIVIR PLUS CONVALESCENT PLASMA THERAPY IS EFFECTIVE TO TREAT COVID-19 PNEUMONIA IN B-CELL DEPLETED PATIENTS WITH HEMATOLOGICAL MALIGNANCIES |
| title_fullStr | PB2276: EARLY ADMINISTRATION OF REMDESIVIR PLUS CONVALESCENT PLASMA THERAPY IS EFFECTIVE TO TREAT COVID-19 PNEUMONIA IN B-CELL DEPLETED PATIENTS WITH HEMATOLOGICAL MALIGNANCIES |
| title_full_unstemmed | PB2276: EARLY ADMINISTRATION OF REMDESIVIR PLUS CONVALESCENT PLASMA THERAPY IS EFFECTIVE TO TREAT COVID-19 PNEUMONIA IN B-CELL DEPLETED PATIENTS WITH HEMATOLOGICAL MALIGNANCIES |
| title_short | PB2276: EARLY ADMINISTRATION OF REMDESIVIR PLUS CONVALESCENT PLASMA THERAPY IS EFFECTIVE TO TREAT COVID-19 PNEUMONIA IN B-CELL DEPLETED PATIENTS WITH HEMATOLOGICAL MALIGNANCIES |
| title_sort | pb2276: early administration of remdesivir plus convalescent plasma therapy is effective to treat covid-19 pneumonia in b-cell depleted patients with hematological malignancies |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431478/ http://dx.doi.org/10.1097/01.HS9.0000851932.19116.3c |
| work_keys_str_mv | AT pinczesli pb2276earlyadministrationofremdesivirplusconvalescentplasmatherapyiseffectivetotreatcovid19pneumoniainbcelldepletedpatientswithhematologicalmalignancies AT magyarif pb2276earlyadministrationofremdesivirplusconvalescentplasmatherapyiseffectivetotreatcovid19pneumoniainbcelldepletedpatientswithhematologicalmalignancies AT payere pb2276earlyadministrationofremdesivirplusconvalescentplasmatherapyiseffectivetotreatcovid19pneumoniainbcelldepletedpatientswithhematologicalmalignancies AT farkask pb2276earlyadministrationofremdesivirplusconvalescentplasmatherapyiseffectivetotreatcovid19pneumoniainbcelldepletedpatientswithhematologicalmalignancies AT ujfalusis pb2276earlyadministrationofremdesivirplusconvalescentplasmatherapyiseffectivetotreatcovid19pneumoniainbcelldepletedpatientswithhematologicalmalignancies AT dioszegia pb2276earlyadministrationofremdesivirplusconvalescentplasmatherapyiseffectivetotreatcovid19pneumoniainbcelldepletedpatientswithhematologicalmalignancies AT demea pb2276earlyadministrationofremdesivirplusconvalescentplasmatherapyiseffectivetotreatcovid19pneumoniainbcelldepletedpatientswithhematologicalmalignancies AT sikm pb2276earlyadministrationofremdesivirplusconvalescentplasmatherapyiseffectivetotreatcovid19pneumoniainbcelldepletedpatientswithhematologicalmalignancies AT nagyg pb2276earlyadministrationofremdesivirplusconvalescentplasmatherapyiseffectivetotreatcovid19pneumoniainbcelldepletedpatientswithhematologicalmalignancies AT hevessyz pb2276earlyadministrationofremdesivirplusconvalescentplasmatherapyiseffectivetotreatcovid19pneumoniainbcelldepletedpatientswithhematologicalmalignancies AT nagyb pb2276earlyadministrationofremdesivirplusconvalescentplasmatherapyiseffectivetotreatcovid19pneumoniainbcelldepletedpatientswithhematologicalmalignancies AT illesa pb2276earlyadministrationofremdesivirplusconvalescentplasmatherapyiseffectivetotreatcovid19pneumoniainbcelldepletedpatientswithhematologicalmalignancies |